Navigation Links
Study finds flexible-fiber CO2 laser safe in endoscopic endonasal transsphenoidal surgery
Date:8/16/2011

(Boston) A new study has shown the Flexible-Fiber CO2 laser to safely cut and coagulate during endoscopic assisted transsphenoidal craniotomies (TSC) without the line of sight problems encountered with conventional CO2 lasers. The findings, reported by researchers from Boston Medical Center (BMC) and Boston University School of Medicine (BUSM), appear in the July/August issue of World Neurosurgery. This is the first study to report the utility of flexible-fiber CO2 laser-assisted ablation in TSC.

The implementation of endoscopy in transsphenoidal surgery for pituitary tumors and other sellar lesions has been one of the most recent significant advances for the treatment of these tumors. This is bolstered by the demonstration of its safety and relative advantages over traditional microscope-based approaches. The long wavelength of the carbon dioxide (CO2) laser has been demonstrated to have high absorption in tissue and water, with rapid conversion of light energy into heat within a small volume of tissue. This property makes the CO2 laser an excellent cutting and ablation tool because it causes minimal thermal damage to adjacent tissue.

The researchers performed a retrospective chart review on 16 patients who underwent flexible-fiber CO2 laser-assisted endoscopic ESS. All tumor pathology types were considered. Results were assessed based on hormone status, tumor size, pathology, complications and resection rates. Pituitary lesions with an average size of 22.7 mm were identified by radiographic and pathologic criteria. The researchers found surgery had a low rate of complication, (three patients) and no laser-related complications were encountered.

According to the authors, because of the small working space, the propensity for bleeding, and the amount of soft tissue and osteogenic dissection involved, the use of flexible-fiber CO2 lasers in ESS is ideal.

Because this is a feasibility and safety study, the authors cannot draw any conclusions regarding outcomes compared with traditional endoscopic transsphenoidal methods, including any difference in time required for laser surgery. However, as their experience has increased they have seen improved time efficiency with regard to laser set up and use.

"The flexible-fiber CO2 laser tool described and utilized in this report is ideally suited for endoscopic assisted TSC because of the narrow corridors and difficulty in using conventional cutting and coagulating instruments," said study co-author author Anand K. Devaiah, MD, FACS, an otolaryngologist at BMC and associate professor of otolaryngology and neurological surgery at BUSM. Devaiah has worked extensively with this system in pioneering applications for minimally invasive surgery, and works with the CO2 laser fiber company, OmniGuide, as a consultant. "Because most pituitary tumors are soft, the CO2 laser was not used extensively for tumor resection in this series, but we have found it very helpful in removing recurrent pituitary adenomas where tumor consistency is often more fibrous and dural scarring may be extensive," added Devaiah.

"Further study of this promising surgical tool is being investigated in other areas of neurosurgery including tumors of the brains and spinal cord," said senior author Lawrence Chin, MD, chief of neurosurgery at BMC and professor and chairman of neurosurgery at BUSM.


'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Study finds 15 minutes of moderate daily exercise lengthens life
2. Nut-allergy sufferers face prejudice -- new study
3. Many More Kids Hospitalized for Mental Illness: Study
4. Chinese Herbs Equal to Tamiflu in Reducing H1N1 Fever: Study
5. Study Supports Selective Use of Drug-Coated Stents
6. Vitamin D Levels Linked to Certain Skin Cancers, Study Finds
7. Study suggests seeing a neurologist helps people with Parkinsons live longer
8. Music Eases Cancer Patients Anxiety: Study
9. Cardiologists Often Miss Heart Defects in Young Athletes: Study
10. Common themes emerge in hospitals anti-MRSA efforts: Study
11. Prehistoric Water Reptiles Social Life Similar to Dolphins: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Ten outstanding teachers in the Greater Houston area ... will win a visit by a Houston Texans player, two tickets to a Texans ... years old can visit texanschecking.com/stars to nominate their favorite teacher with an essay of ...
(Date:8/16/2017)... Georgia (PRWEB) , ... August 16, 2017 , ... ... in Atlanta, opened their doors. They celebrate 30 years in business this year, ... create an up-to-date, inviting, tranquil space to serve their patients. , It ...
(Date:8/16/2017)... ... August 16, 2017 , ... Maury Regional Health has announced ... draws. By broadly deploying AccuVein devices, Maury Regional Medical Center is making vein visualization ... out of a needle stick and more importantly, helps our staff members locate a ...
(Date:8/16/2017)... ... 2017 , ... A global leader in the treatment of clubfoot, CURE ... Indian states—bringing the country one step closer to eliminating clubfoot as a lifelong disability ... on track to enroll 10,000 children in the clubfoot treatment program in this year ...
(Date:8/16/2017)... ... ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has announced their ... a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their content will ... in 2018. Proceeds will be going to further health research. , Fusion Flix ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
(Date:8/2/2017)... 2017   Marshall County Hospital in Benton, Kentucky has ... of hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ... pathogens such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)... , Aug. 1, 2017   CerSci Therapeutics , ... Dallas, Texas , has received notice from the ... Institutes of Health (NIH) that it has been awarded ... totaling over $650,000 in 2017 with an additional $1,000,000 ... Investigational New Drug application of their lead non-opioid drug ...
Breaking Medicine Technology: